We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-6.42%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.29B
AUM Growth
+$73M
Cap. Flow
+$288M
Cap. Flow %
8.77%
Top 10 Hldgs %
33.54%
Holding
352
New
136
Increased
52
Reduced
76
Closed
78

Top Buys

Rank Stock Value
1
LIVN icon
LivaNova
LIVN
+$42.5M
2
MAPS
WM TECHNOLOGY INC A
MAPS
+$23.3M
3
SEER icon
Seer Inc
SEER
+$20.8M
4
GKOS icon
Glaukos
GKOS
+$17.9M
5
COO icon
Cooper Companies
COO
+$17.1M

Top Sells

Rank Stock Value
1
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
+$60.7M
2
NTLA icon
Intellia Therapeutics
NTLA
+$26.2M
3
ORGO icon
Organogenesis Holdings
ORGO
+$19.9M
4
LLY icon
Eli Lilly
LLY
+$15.1M
5
CMIIU
CM Life Sciences II Inc. Unit
CMIIU
+$14.1M

Sector Composition

Rank Sector Weight
1 Healthcare 33.25%
2 Consumer Staples 0.8%
3 Technology 0.71%
4 Industrials 0.71%
5 Materials 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALC icon
26
PUT
Alcon
ALC
$36.4B
$29M 0.88%
+360,000
New +$27.7M
TDOC icon
27
PUT
Teladoc Health
TDOC
$1.24B
$27.9M 0.85%
220,000
+190,000
+633% +$27.7M
NTRA icon
28
Natera
NTRA
$45.1B
$26.8M 0.82%
240,693
+23,877
+11% +$2.74M
OM icon
29
Outset Medical
OM
$90.6M
$26.8M 0.81%
36,079
+11,230
+45% +$7.65M
UHS icon
30
PUT
Universal Health Services
UHS
$9.94B
$26.3M 0.8%
190,000
+91,800
+93% +$13.9M
DXCM icon
31
PUT
DexCom
DXCM
$33.8B
$24.6M 0.75%
180,000
+80,000
+80% +$10.1M
MAPS
32
DELISTED
WM TECHNOLOGY INC A
MAPS
$23.4M 0.71%
+1,612,498
New +$23.3M
TXG icon
33
PUT
10x Genomics
TXG
$7.62B
$23.3M 0.71%
160,000
+95,000
+146% +$16.3M
EXAS
34
PUT
DELISTED
Exact Sciences
EXAS
$22.4M 0.68%
235,000
+186,300
+383% +$19.7M
GH icon
35
PUT
Guardant Health
GH
$22.2B
$21.8M 0.66%
+174,000
New +$20.7M
STAA icon
36
STAAR Surgical
STAA
$1.24B
$21.4M 0.65%
166,193
-10,576
-6% -$1.48M
STAA icon
37
PUT
STAAR Surgical
STAA
$1.24B
$21.2M 0.65%
+165,000
New +$23.1M
BAX icon
38
CALL
Baxter International
BAX
$14.3B
$20.1M 0.61%
+250,000
New +$19.8M
QNCX icon
39
CALL
Quince Therapeutics
QNCX
$33.3M
$19.2M 0.58%
1,045
+545
+109% +$8.67M
IDXX icon
40
PUT
Idexx Laboratories
IDXX
$46.2B
$18.7M 0.57%
+30,000
New +$20.2M
GKOS icon
41
Glaukos
GKOS
$10.7B
$18.2M 0.56%
378,638
+323,638
+588% +$17.9M
VRTX icon
42
CALL
Vertex Pharmaceuticals
VRTX
$134B
$18.1M 0.55%
+100,000
New +$19.5M
CUTR
43
CALL
DELISTED
Cutera, Inc.
CUTR
$18.1M 0.55%
387,900
+95,200
+33% +$4.7M
ATAI icon
44
AtaiBeckley Inc
ATAI
$2.67B
$18M 0.55%
1,291,872
-79,952
-6% -$1.3M
SKIN icon
45
SkinHealth Systems
SKIN
$91.1M
$18M 0.55%
692,437
+252,671
+57% +$5.56M
PACB icon
46
PUT
Pacific Biosciences
PACB
$354M
$17.9M 0.54%
+700,000
New +$20.7M
ARNA
47
CALL
DELISTED
Arena Pharmaceuticals Inc
ARNA
$17.9M 0.54%
+300,000
New +$17.7M
AMRS
48
DELISTED
Amyris Inc.
AMRS
$17.5M 0.53%
1,275,096
+205,959
+19% +$2.95M
IART icon
49
PUT
Integra LifeSciences
IART
$1.35B
$16.8M 0.51%
+245,100
New +$17.3M
COO icon
50
Cooper Companies
COO
$15B
$16.5M 0.5%
+160,000
New +$17.1M
1
2
3 4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q3 2021 Portfolio in Review

As of Q3 2021, Pura Vida Investments held 352 positions worth $3.29B, up 2.3% from $3.21B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Pura Vida Investments deployed $288M of net new capital in Q3 2021, opening 136 new positions and adding to 52 existing holdings. Its largest new stake was WM TECHNOLOGY INC A: 1,612,498 shares worth $23.4M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Consumer Staples and Technology.

On the sell side, the largest reduction was Intellia Therapeutics, an estimated $26.2M trimmed.

  • Pura Vida Investments's largest Q3 2021 buy was WM TECHNOLOGY INC A: 1,612,498 shares worth $23.4M.
  • Pura Vida Investments added most to LivaNova in Q3 2021, an estimated $42.5M increase.
  • Pura Vida Investments's biggest Q3 2021 reduction was Intellia Therapeutics, cutting an estimated $26.2M.
  • Pura Vida Investments fully exited Inovalon Holdings, Inc. Class A Common Stock in Q3 2021, selling an estimated $60.7M.
  • Pura Vida Investments's ten largest holdings make up 34% of its $3.29B portfolio in Q3 2021.
  • Pura Vida Investments opened 136 new positions and closed 78 in Q3 2021.
  • Pura Vida Investments's portfolio value rose 2.3% quarter-over-quarter to $3.29B.

Based on Pura Vida Investments's 13F filing for Q3 2021, filed 15 Nov 2021.